Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Corcept Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$22.3

2024-02-07

Market Capitalization

$2.3 B

2024-02-07

Revenue

$401.9 M

FY, 2022

CreditSafe Score

?
Score changed on Feb 29, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021FY, 2022
Revenue3.3M10.4M26.6M50.3M81.3M159.2M251.2M306.5M353.9M366.0M401.9M
Revenue growth, %156.4%89.4%61.7%
Cost of goods sold91.0K143.0K882.0K1.4M2.1M3.6M5.2M5.5M5.6M5.3M5.4M
Gross profit3.2M10.2M25.7M48.9M79.3M155.6M246.0M301.0M348.3M396.5M
Gross profit margin, %97.2%98.6%96.7%97.3%97.5%97.8%97.9%98.2%98.4%98.7%
General and administrative expense11.3M25.4M31.2M34.9M36.9M45.2M62.4M81.3M100.4M105.3M122.4M152.8M
Operating expense total32.3M39.5M31.2M34.9M52.4M69.1M102.8M156.5M189.4M220.1M236.2M283.8M
EBIT(32.3M)(36.3M)(41.5M)(27.6M)(3.4M)10.2M52.9M89.5M111.6M128.2M124.5M112.6M
EBIT margin, %-1096.8%-400.7%-104.0%-6.8%12.5%33.2%35.6%36.4%36.2%28.0%
Interest income3.0K
Interest expense1.7M4.5M3.8M2.0M
Pre tax profit52.8M92.2M116.7M131.6M125.0M116.2M
Income tax expense(76.3M)16.7M22.5M25.6M12.5M14.8M
Net Income(32.4M)(38.0M)(46.0M)(31.4M)(6.4M)8.1M129.1M75.4M94.2M106.0M112.5M101.4M
EPS0.9

Footer menu